AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 NOV 5 - (NewsRx.com & NewsRx.net) -- Althea Technologies, Inc., a provider of gene-based manufacturing and testing services to accelerate drug development, announced that it has entered into an agreement with Baxter Healthcare Corporation and Baxter Pharmaceutical Solutions, LLC, to co-promote Althea's plasmid DNA manufacturing services and each company's contract fill and finish services.
The goal of this agreement is to provide to companies that are developing plasmid DNA vaccines and other biologics with a solution for their manufacturing and clinical packaging needs from the preclinical stage through commercialization. Althea and Baxter will provide the services in their areas of specialization to better assist the customers with their development and clinical trial needs.
Under the agreement, Althea will provide small batch production and filling capabilities to customers in preclinical through phase III clinical trials. Baxter Pharmaceutical Solutions, LLC, will provide large batch production, packaging and filling services as customers commercialize their products and launch into the market.
"We are extremely pleased to be entering such an agreement with Baxter, a leading supplier of clinical packaging services," stated Rick Hancock, ...